Booth No.5P-07
CategoryOutsourcing
Gradiant Bioconvergence, Inc.
Booth No.：5P-07
Category：Outsourcing
Company Information
Email：
jeyoungryu@gradiantbio.com
TEL： +82-2-6483-1400
Address： 4th floor, 558, Songpa-daero, Songpa-gu, Seoul, Korea, 05510 SOUTH KOREA
URL：
https://www.gradiantbio.com
Gradiant Bioconvergence is the world's first organoid company with the world's largest cancer patient organoid bank, we carry out global businesses such as AI-based anticancer target discovery, biomarker screening, and disease modeling.
Our patient-derived organoids are established with genome analysis and drug reactivity. Our proprietary AI algorithm integrates multifaceted information to derive targets in an unprecedented and innovative way.
Our patient-derived organoids are established with genome analysis and drug reactivity. Our proprietary AI algorithm integrates multifaceted information to derive targets in an unprecedented and innovative way.
Company information
| Address | 4th floor, 558, Songpa-daero, Songpa-gu, Seoul, Korea, 05510 SOUTH KOREA |
|---|---|
| TEL | +82-2-6483-1400 |
| FAX | +82-2-6483-1500 |
| URL | https://www.gradiantbio.com |
| jeyoungryu@gradiantbio.com |
| Product Classification |
Cancer Patient-Derived Organoid (w/ Clinical & NGS data) Alzheimer's disease Patient-Derived Brain Organoid  Brain Organoid Disease Modeling Collaborative Research Drug Screening Service Growth Factors (Noggin, RSPO1/3, FGF7/10) |
|---|
Product introduction
Cancer Patient-Derived Organoid (w/ Clinical & NGS data)Alzheimer's disease Patient-Derived Brain OrganoidBrain Organoid Disease ModelingCollaborative ResearchDrug Screening ServiceGrowth Factors (Noggin, RSPO1/3, FGF7/10)